You have 9 free searches left this month | for more free features.

City

Paris (1)

Condition

Moderate to Severe Dry Eye Syndrome (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Santen SAS (1)

Collaborator

Intervention

nova22007 (1)

nova22007 (ciclosporin 0.1%) (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

nova22007

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Moderate to Severe Dry Eye Syndrome Trial in Paris (NOVA22007 (Ciclosporin 0.1%), NOVA22007)

Completed

Moderate to Severe Dry Eye Syndrome

NOVA22007 (Ciclosporin 0.1%)
NOVA22007

Paris, Île-de-France, France

Hôpital des XV-XX

Jul 15, 2010